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Background: Adipose tissue is an attractive source of cells for therapeutic purposes because of the ease of harvest
and the high frequency of mesenchymal stem cells (MSCs). Whilst it is clear that MSCs have significant therapeutic
potential via their ability to secrete immuno-modulatory and trophic cytokines, the therapeutic use of mixed cell
populations from the adipose stromal vascular fraction (SVF) is becoming increasingly common.
Methods: In this study we have measured a panel of 27 cytokines and growth factors secreted by various
combinations of human adipose-derived cell populations. These were 1. co-culture of freshly isolated SVF with
adipocytes, 2. freshly isolated SVF cultured alone, 3. freshly isolated adipocytes alone and 4. adherent adipose-derived
mesenchymal stem cells (ADSCs) at passage 2. In addition, we produced an ‘in silico’ dataset by combining the
individual secretion profiles obtained from culturing the SVF with that of the adipocytes. This was compared to the
secretion profile of co-cultured SVF and adipocytes. Two-tailed t-tests were performed on the secretion profiles
obtained from the SVF, adipocytes, ADSCs and the ‘in silico’ dataset and compared to the secretion profiles obtained
from the co-culture of the SVF with adipocytes. A p-value of < 0.05 was considered statistically different. To assess the
overall changes that may occur as a result of co-culture we compared the proteomes of SVF and SVF co-cultured with
adipocytes using iTRAQ quantitative mass spectrometry.
Results: A co-culture of SVF and adipocytes results in a distinct secretion profile when compared to all other
adipose-derived cell populations studied. This illustrates that cellular crosstalk during co-culture of the SVF with
adipocytes modulates the production of cytokines by one or more cell types. No biologically relevant differences were
detected in the proteomes of SVF cultured alone or co-cultured with adipocytes.
Conclusions: The use of mixed adipose cell populations does not appear to induce cellular stress and results in
enhanced secretion profiles. Given the importance of secreted cytokines in cell therapy, the use of a mixed cell
population such as the SVF with adipocytes may be considered as an alternative to MSCs or fresh SVF alone.
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Until recently, adipose tissue was considered not only to
be a passive storage organ for triglycerides and therefore
primarily an energy source, but also a structure which
can provide thermal and mechanical insulation. How-
ever, a number of key discoveries identified the import-
ance of adipose tissue as an endocrine organ with major* Correspondence: Benjamin.Herbert@mq.edu.au
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reproduction in any medium, provided the orroles in a wide variety of processes in the body. It is now
known that adipose tissue expresses and secretes an
array of bioactive factors, which act at the autocrine,
paracrine and/or endocrine level. These bioactive factors
are involved in a diverse set of functions including lipid
metabolism, reproduction, angiogenesis, insulin sensitiv-
ity, appetite and energy balance, blood pressure regula-
tion and inflammation [1].
Adipose tissue is a highly vascularized organ contain-
ing a dense network of capillary beds surrounding
mature adipocytes. Associated with these capillary beds
are a number of different cell types. Using collagenase,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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releasing the cells. Subsequent centrifugation results in
floating adipocytes, and pelleted cells, termed the stro-
mal vascular fraction (SVF). The SVF contains high
numbers of T regulatory cells and macrophages, as well
as endothelial cells and smooth muscle cells [2,3]. Add-
itionally, the SVF from adipose tissue is a rich source of
mesenchymal stem cells (MSCs) containing approxi-
mately 500 times more MSCs per gram than bone mar-
row [2,4-6]. MSCs derived from adipose tissue have
been shown to be functionally similar to bone marrow
derived MSC (BM-MSC) however some differences may
exist [7,8]. There has been substantially more research
into the properties and therapeutic potential of BM-
MSC over adipose-derived MSCs (ADSC). However, the
relative abundance of MSCs in adipose tissue compared
to bone marrow, the relative ease of obtaining large
volumes of tissue and the ability to rapidly isolate the
SVF, makes adipose tissue an attractive source of MSCs.
Historically, the focus on MSCs has been defining
their ability to differentiate into cells of the mesenchy-
mal lineage and their subsequent potential therapeutic
use. In recent years there has been a shift in focus to-
wards understanding the therapeutic potential of the
secretions from MSCs and the SVF. The bioactive fac-
tors produced by MSCs and SVF not only modulate the
immune system [9-15] but also have angiogenic, anti-
apoptotic and anti-scarring properties [see [16], and
references therein]. MSCs can modulate the environ-
ment and stimulate tissue repair and regeneration. It is
clear that MSCs have significant therapeutic potential,
either in mixed cell populations or as homogeneous cul-
tured populations. In a number of major jurisdictions,
including North America, the European Community and
Australia, cell therapy is proceeding along two separate
paths, defined by the regulatory environment. In one
path, cells that are harvested and then expanded in cul-
ture or manipulated in other ways are regulated and only
approved for use after extensive safety and efficacy trials.
In an alternative approach, a so-called medical exemp-
tion exists for treatment in a clinic or hospital under the
exclusive professional responsibility of a registered med-
ical practitioner, in order to comply with an individual
medical prescription for a custom-made product for an
individual patient [17]. This is usually interpreted as
encompassing the use of freshly isolated tissue that is
minimally manipulated, in-clinic during the same pro-
cedure, by enzymatic or mechanical means to obtain a
cell population, which is used for autologous treatment.
Any attempt to isolate specific cell populations, for ex-
ample, using antibody coated magnetic beads, would
constitute more than minimal manipulation. The use of
freshly isolated adipose cell populations such as SVF,
alone or in combination with adipocytes, fits withinthese regulatory frameworks. As adipose tissue can be
rapidly processed to prepare a minimally manipulated
and un-cultured mixed cell population for therapeutic
purposes, its use in cell therapy is increasing. In fact,
adipose tissue is unique for this type of cell therapy be-
cause of the high frequency of MSCs compared to other
tissue sources. There is increasing research, clinical trial
and commercial activity along both of the pathways
described. The use of cultured MSCs, and uncultured
freshly isolated adipose SVF, alone or in combination
with adipocytes, are currently available cellular therapies
in Australia, Europe and North America.
In vivo, the multiple cell types that comprise adipose
tissue live in close proximity to each other. Conse-
quently, as part of normal tissue function, there is sig-
nificant cross-talk between the cells, which occurs
though direct cell-cell contact or surface molecular
receptors and secreted factors. Indeed, co-culture experi-
ments have demonstrated complex reciprocal signaling,
between adipose-derived cells [18-20]. We hypothesized
that distinct secretion profiles would be obtained from
the in vitro culture of various mixed adipose-derived cell
populations. To investigate this, we used the largest sin-
gle multi-plex panel (27 analytes) available for measuring
human cytokines, growth factors and chemokines at the
protein level. This panel gives broad coverage of inflam-
matory and anti-inflammatory cytokines, chemokines
and growth factors. These analytes were measured in the
conditioned medium of 1. the entire cellular fraction of
adipose tissue, the SVF co-cultured with adipocytes, 2.
SVF alone, 3. adipocytes and 4. adherent MSCs at pas-
sage two. A key aspect of this study was to observe the
extent to which the secretion profiles obtained from dif-
ferent cell populations were influenced by cross-talk. We
chose to address that by comparing the secretion profile
of SVF cultured with adipocytes to the profile obtained
from adding together the secretion profile of SVF alone
with the secretion profile values of adipocytes alone. We
refer to this computer-generated secretion profile as an
‘in silico’ dataset.
Methods
Isolation of human adipose-derived cell populations
This research was approved by the Macquarie University
human research ethics committee (Ref #: 5201100385).
Written consent was obtained from the patients who parti-
cipated in this study. Human abdominal lipoaspirates were
obtained from five patients undergoing routine liposuction
procedures for cosmetic reasons. For each sample, 200
grams of lipoaspirate was digested with 0.5 mg/mL collage-
nase (Lomb Scientific, USA) mixed with 0.05 mg/mL of
vancomycin (Hospira Australia Pty Ltd, Australia) in a 37°C
water bath for 30 mins with periodic mixing. The digested
samples were passed through an 800 μm mesh and
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cells (SVF) and floating adipocytes. The adipocyte and SVF
fractions were washed separately with saline and centri-
fuged at 1500 x g for 5mins. These freshly isolated fractions
were placed into culture to produce conditioned medium
(see below).
To obtain a population of adherent ADSCs, a portion of
each SVF pellet obtained was placed into a T175cm2 flask
containing Standard Media that consisted of Dulbeccos
Modified Eagle Medium (DMEM; Invitrogen, USA) sup-
plemented with 10% foetal bovine serum (FBS; Bovogen,
Australia) and 1% Penicillin-Streptomycin solution (Invi-
trogen, USA). Media changes were performed every 3
days. The initial media change resulted in removal of non-
adherent cells. Once the adherent ADSCs reached 80%
confluency, cells were passaged using TrypLE express
(Invitrogen, USA). Adherent ADSCs were used at passage
2 for the experiments described in this manuscript.
Confirmation of adherent MSCs
Differentiation potential
Adherent ADSCs were obtained from human lipoaspi-
rate samples as described above. ADSCs were seeded at
a density of 1 x 104 and 5 x 103 cells per cm2 for adipo-
genic and osteogenic differentiation respectively. Control
cells were maintained in Standard Media. Defined adipo-
genic and osteogenic differentiation media formulations
were used as previously described [21]. Media was chan-
ged on both control and differentiated wells every 3 days
for 3 weeks. Upon completion of differentiation, cells
were washed twice with phosphate buffered saline (PBS)
and incubated for 30 mins with 4% paraformaldehyde.
For adipogenic differentiation, the cells were subse-
quently washed with MilliQ water, incubated with 60%
isopropanol, stained with 0.2% Oil Red O solution for 5
mins at room temperature and washed with tap water.
For osteogenic differentiation, the cells were stained with
2% Alizarin red solution for 2 mins at room temperature
and washed 3 times with MilliQ water. Control and dif-
ferentiated cells were imaged using a Carl Zeiss Primo
Vert inverted microscope.
CD Marker characterization
Adherent ADSCs were obtained from human lipoaspi-
rate samples as described above. Cells were liberated
from the flask using TrypLE express, diluted in Standard
Media and centrifuged at 2000 x g for 5 mins. The cells
were washed in PBS and resuspended in PBS with 2%
FBS. The cells were stained with the following anti-
bodies, which were all sourced from Becton Dickinson:
CD34-FITC (#555821), CD45-FITC (#555482), CD73-PE
(#550257), CD90-FITC (#555595), and CD105-PE
(#560839) and incubated on ice for 45 mins. Cells were
washed with ice cold PBS, centrifuged at 300 x g for5 mins and resuspended in 1x FACS Lysing Solution
(Becton Dickinson, USA). The cells stained with FITC
conjugated antibodies were resuspended in Propidium
iodide (10 μg/mL) and isoflow. Stained and unstained
control cells were analysed using a FacsScan flow
cytometer (Becton Dickinson, USA).
Production of conditioned medium
A portion of each of the freshly isolated SVF pellets or
cultured adherent ADSCs were filtered through 35 μm
nylon mesh topped tubes (Becton Dickinson, USA). Sam-
ples were enumerated and the viability determined in Tru-
Count tubes (Becton Dickinson, USA) containing isoflow
(Becman Coulter, USA) Propidium iodide (10 μg/mL;
Sigma, USA) and Syto11 (1 μM; Invitrogen, USA) using a
FacsScan flow cytometer (Becton Dickinson, USA). The
total number of viable cells in each of the freshly isolated
SVF preparations and adherent cell cultures were deter-
mined. On the basis of the viable cell counts, the volume
of the freshly isolated SVF or adherent cell suspensions
required to seed 1.5 million viable nucleated cells was
transferred to separate T75cm2 culture flasks. Adipocytes
are difficult to accurately enumerate [22] and therefore
they were normalised between biological replicates by
adding a 3.5 mL volume of the adipocyte enriched frac-
tion. To the co-culture flask, 3.5 mL of freshly isolated
adipocytes were added. A volume of 3.5 mL of freshly iso-
lated adipocytes alone was transferred to a T25cm2 culture
flask. The flask was inverted for incubation to enable opti-
mal contact between the adipocytes and the treated sur-
face of the culture flask. This type of culture is standard
for adipocytes and is referred to as ‘ceiling culture’ [23].
The cell suspensions were incubated in Standard Media.
All flasks were incubated at 37°C with 5% CO2 for 72
hours without media changes. The conditioned medium
was collected, centrifuged at 4980 x g for 10 mins and
stored at −80°C.
Bio-Plex analysis
Conditioned medium samples were filtered through 0.2
μm Nanosep MF Centrifugal Devices with Bio-InertW
Membrane (Pall Scientific, USA) for 5 mins at 9000 x g.
Samples (50 μL) of each filtered sample was analysed
using the Bio-Plex Pro Human Cytokine 27-plex assay
(Bio-Rad, USA) according to the manufacturer’s instruc-
tions. The washing steps were performed on the Bio-
Plex Pro II magnetic wash station and the data was
acquired using the Bio-Plex 200 system with version 5.0
software (Bio-Rad, USA). The resultant cytokine concen-
trations obtained from the adipocyte ceiling cultures
were adjusted for the difference in media volumes. IL-5
has not been included in the data analysis as it was not
detected in any of the conditioned medium samples.
The average concentration of each cytokine produced by
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the five biological replicates. To produce the ‘in silico’
dataset, the concentration of each cytokine obtained
from the in vitro culturing of the SVF and adipocytes
separately were combined for each biological replicate.
The average concentration of each cytokine in this ‘in
silico’ dataset was then calculated from the five bio-
logical replicates. The results are presented as the
mean ± SEM. A two-tailed t-test was used to test the sig-
nificance between the average concentration of each
cytokine in the SVF, adipocytes, ADSCs and ‘in silico’
datasets compared to the co-culture dataset. Unless
otherwise stated, p-values < 0.05 were considered statisti-
cally significant.
Sample preparation and proteomic analysis using iTRAQ
A lipoaspirate sample was processed to obtain the SVF
and adipocytes as described above. Four flasks were each
seeded with approximately 29 million viable SVF cells.
The two flasks designated as the co-culture flasks each
received 30 mL of adipocytes and the two SVF only
flasks received 30 mL of wash solution (saline with 0.05
mg/mL vancomycin). The volume in each flask was nor-
malized to 80 mL with Standard Media. The flasks were
incubated at 37°C with 5% CO2 for 72 hours without
media changes. Non-adherent cells from each flask were
collected from the conditioned medium by centrifuga-
tion at 1500 x g for 5 mins. Adherent cells were washed
in HG DMEM, stripped from each flask using TrypLE
express and centrifuged at 1500 x g for 5 mins. The
non-adherent and adherent SVF cell pellets from each
flask were washed in PBS, snap frozen in liquid nitrogen
and stored at −80°C. Complete cell lysis and protein
denaturation was achieved by adding 1% SDS and 100
mM TEAB to the thawed pellets followed by sonication.
At this point, the protein solutions from the adherent
and non-adherent cell pellets for each flask were com-
bined. The samples were boiled, sonicated and centri-
fuged at 21 000 x g for 10 mins. Proteins were acetone
precipitated, centrifuged at 4980 x g for 6 mins and the
resultant pellets were solubilized in 1% SDS and 100mM
TEAB followed by sonication, boiling and centrifugation
at 21 000 x g for 5 mins. Samples were processed
through columns (micro Bio-spin, P6 in SSC; Bio-RAD,
USA) according to the manufacturer’s instructions. 100
μg of each of the 4 samples was reduced with tris(2-car-
boxyethyl)phosphine, alkylated with methyl metha-
nethiosulfonate and digested with trypsin. The resultant
peptides from each sample were labeled with 1 of the 4
iTRAQ labels (114, 115, 116 or 117) according to the
manufacturer’s instructions (AB Sciex, USA).
The labeled samples were cleaned and fractionated by
SCX HPLC. Buffer A was 5 mM phosphate and 25%
acetonitrile with a pH of 2.7 and buffer B was 5 mMphosphate, 350 mM potassium chloride and 25% Aceto-
nitrile with a pH 2.7. The dried iTRAQ labeled samples
were resuspended in buffer A. After sample loading and
washing with buffer A, buffer B concentration was
increased from 10% to 45% in 70 mins, increased quickly
to 100% and maintained at 100% for 10 mins at a flow
rate of 300 μl/min. The eluent from SCX was collected
every 2 mins at the beginning of the gradient and at 4
minutes intervals thereafter. The SCX fractions were
each concentrated and desalted using a Michrome pep-
tide Captrap (Michrom Bioresources, USA). The peptide
trap was then switched into line with the 150 μm x 10
cm C18 3 μm 300 A ProteCol analytical column (SGE,
Australia). Peptides were eluted from the column using
a 120 min linear solvent gradient. The reverse phase
nanoLC eluent was subject to positive ion nanoflow
electrospray analysis in an information dependant acqui-
sition mode (IDA) on a Qstar Elite mass spectrometer
(AB Sciex, USA). In IDA mode a TOFMS survey scan
was acquired (m/z 370–1600, 0.5 second), with the three
most intense multiply charged ions (counts >70) in the
survey scan sequentially subjected to MS/MS analysis.
MS/MS spectra were acquired in the mass range m/z
100–1600. The experimental nanoLC ESI ms/ms data
were submitted to ProteinPilot V4.0 (AB Sciex, USA) for
data processing using Homo sapiens species. Bias cor-
rection was selected. The detected protein threshold
(unused ProtScore) was set as larger than 1.3 (better




A cell is recognized as an MSC if it meets the criteria
outlined in the International Society for Cellular Ther-
apy position statement, which involves displaying plastic
adherence, the ability to differentiate into specialized
mesenchymal cells, expression of CD73, CD90 and
CD105 and lack of expression of the hematopoietic mar-
kers, CD34 and CD45 [24]. To confirm the adherent cell
population obtained from the SVF in this study were
MSCs, we analyzed the differentiation capabilities and
CD marker profiles of these cells. Following treatment
with standard adipogenic and osteogenic differentiation
media formulations, the adherent cells stained positive
for lipid accumulation following Oil Red O staining
(Additional file 1: Figure S1a) and for calcium deposition
with Alizarin red staining (Additional file 1: Figure S1c).
Control cells were negative for lipid accumulation and
calcium deposition (Additional file 1: Figure S1b and d
respectively). The CD marker characterization demon-
strated that the adherent cells expressed CD73, CD90
and CD105, but lacked expression of CD34 and CD45
(data not shown). These results confirm that the
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identification criteria.
Analysis of overall cytokine secretion profiles from
adipose derived cell populations
To compare the effect of co-culturing the entire cellular
fraction (the co-culture dataset) isolated from adipose
tissue, versus the SVF and adipocyte fractions separately,
an ‘in silico’ dataset was produced. This was achieved by
adding the individual secretion profile values obtained
from the two separate fractions. This ‘in silico’ dataset
has been included in all analyses.
As the co-culture samples contained the entire cellular
fraction of adipose tissue, this dataset was used as the
reference to examine the differences in the secretion
profiles obtained from the other adipose-derived cell
populations. A log of the ratio of individual cytokine
concentrations in the co-culture dataset compared to
the other cell populations studied and the ‘in silico’ data-
set was calculated. The results are illustrated in Figure 1
in which the cytokines are presented in the same order
in all graphs. From Figure 1A, it is evident that with the
exception of PDGF and MIP-1β, increased levels of the
cytokines measured were secreted from the co-cultureFigure 1 Comparison of secretion profiles of the SVF co-cultured with
silico’ datasets. The log of the ratio of each cytokine concentration betwe
results (co-culture) and the SVF (A), ‘in silico’ dataset (B), adipocytes (C) and
cytokines are ordered based on the comparison between the co-culture ansamples when compared to the SVF alone. A similar
trend was seen when the co-culture samples were com-
pared to the ‘in silico’ dataset (Figure 1B). However, a
number of the cytokines in this comparison were
present at similar levels in the conditioned medium from
the two sample types. The levels of all 26 cytokines were
present in higher concentrations in the co-culture data-
set when compared to the adipocyte only dataset, with
G-CSF exhibiting the highest increase of 14,242 pg/mL
(174-fold increase; Figure 1C). The comparison between
the co-culture and ADSC datasets exhibited the greatest
fluctuations in cytokine concentrations (Figure 1D).
There were 6 cytokines (IL-7, IL-10, IL-12, IL-13, IFN-γ
and VEGF) secreted at higher concentrations by ADSCs,
and 2 (IL-2, and IL-6) that were secreted in similar con-
centrations by both sample types. The remaining 18
cytokines were secreted at higher concentrations by the
co-culture samples.
To investigate whether any trends were evident in the
cytokines secreted in higher or lower levels by each
adipose-derived cell population, the cytokines were cate-
gorized into pro-inflammatory, anti-inflammatory, che-
mokines, growth factors and those with dual roles.
Following categorization, a two-tailed t-test wasadipocytes compared to the SVF, adipocytes, ADSCs and ‘in
en the stromal vascular fraction (SVF) co-cultured with adipocyte
the adipose-derived stem cells (ADSCs; D) was calculated. The
d SVF datasets (A).
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cytokine secreted by the SVF, adipocytes, ADSCs, and
the ‘in silico’ datasets were statistically different from the
co-culture dataset.
Pro-inflammatory cytokines
Of the 27 cytokines measured in this study, 8 are consid-
ered to be pro-inflammatory based on their in vivo and
in vitro activities defined in the literature. IFN-γ and IL-
12 were significantly higher in the co-culture dataset
when compared to the SVF and adipocyte samples
(p-value < 0.05) and the ‘in silico’ dataset (p-value < 0.1;
Figures 2A and E). In contrast, ADSCs produced signifi-
cantly higher levels of these two cytokines when com-
pared to the co-culture dataset (p-value < 0.05;
Figures 2A and E). The levels of the remaining pro-
inflammatory cytokines were significantly higher in the
co-culture dataset when compared to the ADSC and adi-
pocyte datasets (p-value < 0.05; Figure 2).
Anti-inflammatory cytokines
A comparison of the ‘in silico’ and co-culture datasets
showed no statistical differences between the levels of the
anti-inflammatory cytokines, IL-1Ra, IL-4, IL-10 and IL-
13 measured. The co-culture dataset had significantly
higher levels of IL-1Ra than the other cell populations
studied (p-value < 0.05) but was not significantly different
from the ‘in silico’ dataset (Figure 3A). In contrast, IL-4
was produced in significantly lower concentrations by the
adipocyte fraction only when compared to the co-culture
dataset (p-value= 0.001; Figure 3B). IL-10 and IL-13 were
produced in significantly higher levels by ADSCs and sig-
nificantly lower levels by adipocytes when compared to
the co-culture dataset (p-values < 0.05; Figures 3C and D).
Chemokines
Eotaxin, MIP-1α, MIP-1β and RANTES all exhibited
similar profiles with significantly lower concentrations
produced by the ADSC and adipocyte samples when
compared to the co-culture dataset (p-value < 0.05;
Figures 4A, D, E and F respectively). The co-culture
dataset contained significantly higher concentrations of
IP-10 than the other cell populations studied (p-value <
0.05) and the ‘in silico’ dataset (p-value < 0.1; Figure 4B).
There were no significant differences between the levels
of MCP-1 in the co-culture dataset and the other cell
populations studied (Figure 4C).
Growth factors
bFGF and G-CSF exhibited similar profiles with signifi-
cantly lower concentrations seen in all cellular fractions
studied (including the ‘in silico’ dataset) when compared
to the co-culture dataset (p-values < 0.05; Figure 5A and
B). The co-culture dataset had significantly higherconcentrations of GM-CSF than the adipocyte only data-
set (p-value = 4.2E-4; Figure 5C). The conditioned
medium from ADSCs contained significantly increased
concentrations of IL-7 and VEGF than the co-culture
dataset (p-values = 0.004 and 0.001 respectively;
Figures 5D and F). SVF and adipocytes however pro-
duced significantly lower levels of IL-7 and VEGF than
the co-culture dataset (p-value < 0.05; Figures 5D and F).
Furthermore, VEGF levels were significantly lower in the
‘in silico’ dataset when compared to the co-culture sam-
ples (p-value = 0.038; Figure 5F). Interestingly, large bio-
logical variation was seen in the levels of PDGF in the
SVF samples. The secreted concentration of PDGF was
not significantly different in the ‘in silico’ dataset or any
of the cell populations analysed when compared to the
co-culture dataset (Figure 5E).
Cytokines with dual roles
IL-2 and IL-6 are the 2 cytokines in the Bio-Plex panel con-
sidered to have both pro- and anti-inflammatory activities
under different conditions. The ADSC and adipocyte sam-
ples secreted significantly lower levels of IL-2 when com-
pared to the co-culture dataset (p-values=0.049 and 2.3E-4
respectively; Figure 6A). IL-6 was secreted in significantly
lower levels by both the SVF and adipocyte fractions (p-
value <0.05) as well as the ‘in silico’ dataset (p-value <0.1)
when compared to the co-culture dataset (Figure 6B).
Summary of the Bio-Plex data
Table 1 contains a summary of the number of statisti-
cally significant cytokines between each of the fractions
(SVF, adipocytes, ADSCs and ‘in silico’ datasets) with re-
spect to the co-culture dataset, which contained secre-
tions from the entire cellular makeup of adipose tissue.
The in vitro co-culture of the SVF with adipocytes
resulted in significantly increased secretion of 9, 15, 23
and 3 factors when compared to the SVF, ADSC, adipo-
cyte and ‘in silico’ datasets respectively (p-value < 0.05).
However, an additional 4 factors were present in signifi-
cantly increased concentrations (p-value < 0.1) in the co-
culture datasets when compared to the levels seen in the
‘in silico’ dataset. There were no cytokines secreted in
significantly higher concentrations by the SVF alone,
adipocytes alone, or the calculated ‘in silico’ dataset
when compared to the co-culture dataset. However, iso-
lation and subsequent culturing of adherent ADSCs did
result in 6 cytokines being secreted in significantly
higher concentrations than in the co-culture dataset.
iTRAQ proteomic analysis of the SVF intra-cellular
proteome cultured in the presence or absence of
adipocytes
The in vitro co-culture of the SVF with adipocytes
resulted in a distinct secretion profile when compared to
Figure 2 (See legend on next page.)
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Figure 2 Average concentration of pro-inflammatory cytokines secreted by adipose-derived cell populations. The concentrations of the
pro-inflammatory cytokines, IFN-γ (A), IL-1β (B), IL-8 (C), IL-9 (D), IL-12 (E), IL-15 (F), IL-17 (G) and TNF-α (H) were measured in the conditioned
medium of the stromal vascular fraction (SVF) co-cultured with adipocytes (co-culture), SVF, adipose-derived stem cells (ADSC), and adipocytes, as
well as the ‘in silico’ dataset. The reported values are the average of 5 biological replicate ± SEM. An * denotes a p-value of≤ 0.05 and an **
denotes a p-value≤ 0.1 when compared to the co-culture dataset.
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pocytes alone and the ‘in silico’ dataset. To supplement
the secretion profile data, we wanted to determine if co-
culture or isolated culture would have any significant
effects on the intra-cellular proteome of the SVF. We
were particularly interested in whether co-culture or iso-
lated culture would affect the cells in a negative way that
may, in turn, affect their suitability as a therapeutic. To
achieve this we used a quantitative proteomic approach,
iTRAQ, to examine the intra-cellular proteome of the
SVF following a 72-hour culture in the presence or ab-
sence of adipocytes. The 4-plex iTRAQ system enables a
comparison of 4 different samples by labeling the tryptic
peptides from each sample with a different isobaric tag.Figure 3 Average concentration of anti-inflammatory cytokines secre
anti-inflammatory cytokines, IL-1Ra (A), IL-4 (B), IL-10 (C), IL-13 (D), were me
(SVF) co-cultured with adipocytes (co-culture), SVF, adipose-derived stem c
reported values are the average of 5 biological replicate ± SEM. An * denotFollowing fragmentation by collision-induced dissoci-
ation, reporter ions of different masses are generated
and the ratios of these reporter ion peak areas are subse-
quently used to determine the relative abundance of the
peptides from the 4 samples. In our experimental design,
we chose to analyze technical replicates of the SVF
intra-cellular proteome following culture in the presence
or absence of adipocytes in a 4-plex iTRAQ system. We
identified a total of 2200 proteins from 23,073 distinct
peptides, which were identified from 70475 spectra using
this method. In each comparison between the SVF intra-
cellular proteome incubated with or without adipocytes,
a threshold of > 1.2 and < 0.8 was assigned for the
iTRAQ ratio intensities obtained. This represents anted by adipose-derived cell populations. The concentrations of the
asured in the conditioned medium of the stromal vascular fraction
ells (ADSC), and adipocytes, as well as the ‘in silico’ dataset. The
es a p-value of≤ 0.05 when compared to the co-culture dataset.
Figure 4 Levels of chemokines measured in conditioned medium of adipose-derived cell populations. The concentrations of the
chemokines, eotaxin (A), IP-10 (B), MCP-1 (C), MIP-1α (D), MIP-1β (E) and RANTES (F) were measured in the conditioned medium of the stromal
vascular fraction (SVF) co-cultured with adipocytes, SVF, adipose-derived stem cells (ADSC), and adipocytes, as well as the ‘in silico’ dataset. The
reported values are the average of 5 biological replicate ± SEM. An * denotes a p-value of≤ 0.05 and an ** denotes a p-value≤ 0.1 when
compared to the co-culture dataset.
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http://www.translational-medicine.com/content/10/1/172increase or decrease in protein concentration of more
than 20%. Table 2 contains the protein identifications,
percentage of protein coverage, number of unique pep-
tides, and fold change of the protein in each comparison
of the SVF proteome incubated with adipocytes versus
the SVF alone for all 24 proteins that showed a signifi-
cant change (p < 0.05). From this table, it is evident that
of the 24 proteins which were significantly changed, 17were up-regulated and 7 were down-regulated in the
intra-cellular proteome of the SVF incubated with adipo-
cytes when compared to the SVF incubated alone. It is
evident from the differentially expressed proteins in
Table 2 that short-term in vitro culture of the SVF in the
absence of adipocytes did not result in massive changes
in the intra-cellular proteome of the SVF. This result
indicates that under these experimental conditions the
Figure 5 Concentration of growth factors measured in conditioned medium of adipose-derived cell populations. The concentrations of
the growth factors, bFGF (A), G-CSF (B), GM-CSF (C), IL-7 (D), PDGF-bb (E) and VEGF (F) were measured in the conditioned medium of the
stromal vascular fraction (SVF) co-cultured with adipocytes, SVF, adipose-derived stem cells (ADSC), and adipocytes, as well as the ‘in silico’ dataset.
The reported values are the average of 5 biological replicate ± SEM. An * denotes a p-value of≤ 0.05 when compared to the co-culture dataset.
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vate stress responses in the SVF that caused substantial
changes at the intra-cellular proteomic level.
Discussion
The purpose of this study was to compare the secretion
profiles obtained from human adipose-derived cell popula-
tions. We used a panel of 27 cytokines to analyse the
in vitro secretion profiles obtained from the entire cellular
composition of adipose tissue (the co-culture dataset),SVF alone, adipocytes alone and cultured ADSCs. Further-
more, we produced an ‘in silico’ dataset by combining the
individual secretion profiles obtained from culturing the
SVF with that of the adipocytes. This ‘in silico’ dataset was
used to determine what effect, if any, the cross-talk be-
tween SVF and adipocytes, had on the secretion profiles.
We found that co-culturing the SVF with adipocytes
resulted in significantly increased concentrations of be-
tween 3 and 23 cytokines when compared to the other cell
populations studied (Table 1). Interestingly our results
Figure 6 Concentration of cytokines with dual roles measured in conditioned medium of adipose-derived cell populations. The
concentrations of the cytokines, IL-2 (A), and IL-6 (B) were measured in the conditioned medium of the stromal vascular fraction (SVF) co-
cultured with adipocytes, SVF, adipose-derived stem cells (ADSC), and adipocytes, as well as the ‘in silico’ dataset. The reported values are the
average of 5 biological replicate ± SEM. An * denotes a p-value of≤ 0.05 and an ** denotes a p-value≤ 0.1 when compared to the co-culture
dataset.
Blaber et al. Journal of Translational Medicine 2012, 10:172 Page 11 of 16
http://www.translational-medicine.com/content/10/1/172illustrate that no component of adipose tissue secretes an
exclusive anti-inflammatory or pro-inflammatory profile.
Instead, the cytokine secretion profiles vary between each
of the 4 cellular fractions of adipose tissue as well as the
‘in silico’ dataset. We also used quantitative proteomics
(iTRAQ) to determine if co-culture or isolated culture
would have any significant effects on the intra-cellular
proteome of the SVF. We found 17 proteins significantly
up-regulated and 7 proteins significantly down-regulated
in the proteome of the SVF co-cultured with adipocytes
when compared to the proteome of the SVF cultured
alone. However, none of these proteins indicated that the
presence or absence of adipocytes under these experimen-
tal conditions was inducing stress-responses in the SVF
cells resulting in negative changes in the cellular proteome
of these cells.
Increased secretion of cytokines by the co-culture of SVF
with adipocytes
The ‘in silico’ dataset of SVF and adipocytes produces a
similar secretion profile to the co-culture of SVF and
adipocytes. However, co-culturing the SVF with adipo-
cytes produced significantly higher concentrations of 3
cytokines (p < 0.05) and an additional 4 with a p < 0.1
than the ‘in silico’ dataset. In particular, the co-culture ofTable 1 Summary of in vitro secretion profiles from adipose-d




'in silico' dataset 3
a Number of cytokines produced in significantly (p-value < 0.05) increased or decrea
compared to the co-culture dataset.SVF with adipocytes produced a growth factor boost
with VEGF, G-CSF and bFGF increased by 2.89, 6.97 and
2.74 fold respectively compared to the ‘in silico’ dataset.
This result suggests that the SVF and adipocyte cells are
interacting in a manner that enhances their paracrine
signaling by inducing the production of these factors by
one or more of the cell types. These secretion data sup-
port that hypothesis and demonstrate that analyzing in-
dividual cell populations will provide an incomplete
understanding of the cytokine activity of adipose tissue.
The analysis of the secretion profiles of these cell popu-
lations is one way to illustrate their paracrine signaling
activities. However, cells can also use mRNA and micro-
RNA in microvesicles to communicate [25], although
the downstream effects on protein expression and secre-
tion profiles is not clear. It is emerging that there may
be a variety of non-protein cross talk mechanisms be-
tween cells that were not investigated in this study. Our
objective was not a comprehensive analysis of the cross-
talk in adipose tissue, rather to use secretion profiling
and proteomics to understand the likely in vivo potency
of mixed cell vs homogeneous populations.
Considering the SVF cells reside in close proximity to
adipocytes in vivo, and adipose tissue plays a role in a
number of processes within the body, substantial cross-erived cell populations





sed levels by the different adipose-derived cell populations tested when
Table 2 SVF intra-cellular proteome differences following culturing in the presence or absence of adipocytes
UniProt accession No. Protein Name % Coverage
(No. of peptides)
SVF (+) : SVF (−)
115/116
SVF (+) : SVF
(−) 114/117
Significant Up-Regulated Proteins
O60240 Perilipin-1 31 % (9) 2.73 2.44
P33121 Long-chain-fatty-acid–CoA ligase 1 19 % (10) 1.71 2.01
Q99541 Perilipin-2 46 % (15) 1.65 1.34
P23141 Liver carboxylesterase 1 42 % (20) 1.63 1.50
Q9BRX8 Uncharacterized protein C10orf58 31 % (8) 1.53
Q16853 Membrane primary amine oxidase 51 % (52) 1.51 1.35
P21695 Glycerol-3-phosphate dehydrogenase [NAD+], cytoplasmic 24 % (5) 1.46 1.52
Q12797 Aspartyl/asparaginyl beta-hydroxylase 31 % (17) 1.38 1.39
P05091 Aldehyde dehydrogenase, mitochondrial 43 % (19) 1.37 1.37
Q14315 Filamin-C 28 % (37) 1.29 1.56
Q9BXN1 Asporin 33 % (8) 1.29 1.29
Q16836 Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial 39 % (9) 1.29
Q9UHG3 Prenylcysteine oxidase 1 30 % (11) 1.28
P49327 Fatty acid synthase 20 % (29) 1.17 1.48
P42765 3-ketoacyl-CoA thiolase, mitochondrial 50 % (12) 1.17 1.29
P05120 Plasminogen activator inhibitor 2 57 % (24) 1.13 1.50
P09601 Heme oxygenase 1 53 % (15) 1.13 1.41
Significant Down-Regulated Proteins
P15090 Fatty acid-binding protein, adipocyte 85 % (24) 0.86 0.54
P30740 Leukocyte elastase inhibitor 28 % (8) 0.81 0.70
P04179 Superoxide dismutase [Mn], mitochondrial 50 % (14) 0.77
P29966 Myristoylated alanine-rich C-kinase substrate 42 % (9) 0.73
P43490 Nicotinamide phosphoribosyltransferase 45 % (15) 0.68 0.66
P40261 Nicotinamide N-methyltransferase 22 % (4) 0.60 0.65
P20591 Interferon-induced GTP-binding protein Mx1 22 % (8) 0.59
Replicate SVF samples were cultured in the presence (+) or absence (−) of adipocytes for 72 hours in Standard Media. The SVF cells were collected, prepared and
the tryptic peptides were labeled with an isobaric tag (114, 115, 116 or 117) for iTRAQ analysis using a Qstar Elite. A total of 2220 proteins were identified but
only those which were significantly (p-value < 0.05) differentially expressed between the proteomes of the SVF cultured in the presence (+) or absence (−) of
adipocytes have been included. For each of these proteins, the UniProt identification number, protein name, percentage of protein coverage (and number of
unique peptides contributing to the sequence coverage), and fold change between the proteins in the SVF cultured with adipocytes versus the SVF cultured
alone, for both replicates, are included.
Blaber et al. Journal of Translational Medicine 2012, 10:172 Page 12 of 16
http://www.translational-medicine.com/content/10/1/172talk between the cells in adipose tissue is not unex-
pected. Indeed, in vitro experiments have shown signifi-
cant cross-talk between adipocytes and other cells
contained within the SVF such as lymphocytes and
macrophages [19,20,26]. Adipocytes are therefore not
passive storage cells but instead actively secrete a wide
variety of hormones, growth factors, chemokines and
cytokines. Interestingly, no cytokines measured in this
study were found to be significantly increased in the ‘in
silico’ dataset, possibly indicating that positive feedback
mechanisms are involved when adipocytes were co-
cultured with the SVF.
In this study, the in vitro culture of the SVF alone
yielded decreased concentrations of all cytokines mea-
sured, compared to the cytokine profile of co-culturedadipocytes and SVF. Out of the 26 cytokines, 9 were sig-
nificantly lower (p < 0.05) in the SVF, when compared to
the co-culture samples. As no cytokines were secreted in
significantly higher concentrations by the SVF only sam-
ples, it is consistent with our observations that the co-
culture of adipocytes with the SVF involves positive
feedback mechanisms and does not appear to suppress
the production of the cytokines measured in this study.
Increased secretion of cytokines by ADSCs
The in vitro culturing of ADSCs resulted in the secretion
of significantly higher concentrations (p< 0.05) of 6 cyto-
kines (IFN-γ, IL-7, IL-10, IL-12, IL-13, and VEGF) when
compared to the co-culture dataset. Consistent with
standard approaches in the literature [27,28], the ADSC
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selecting for plastic adherence and subsequently
expanding the cells to passage two in vitro. This is a more
selective cell population when compared to the SVF and
co-culture samples. Consequently, the increased secretion
of some cytokines by the isolated adherent ADSCs, when
compared to co-culture samples, may be due to the
increase in cell numbers during culture and the lack of
immune cells and adipocytes regulating their secretions.
Quantitative proteomic analysis of the SVF proteome
following in vitro culture in the presence or absence of
adipocytes
We found 17 proteins significantly up-regulated and 7
proteins significantly down-regulated between the intra-
cellular proteome of the SVF from in vitro co-culture with
adipocytes or isolated culture. Of the 17 proteins signifi-
cantly up-regulated, there were a number of prominent
abundant adipocyte proteins including perilipin-1 [29],
perilipin-2 [30], liver carboxyesterase 1 [31], membrane
primary amine oxidase [32], glycerol-3-phosphate de-
hydrogenase [33], and fatty acid synthase [34]. Membrane
primary amine oxidase, for example, is a major compo-
nent of the adipocyte plasma membrane [32]. The most
likely explanation for the increased level of these proteins
is contamination of the SVF intra-cellular proteome with
adipocyte proteins despite our use of density differentials
to separate the adipocytes from the SVF and the subse-
quent stringent washing of the SVF. However, it is also
possible that different cell types, including the ADSC
population in the SVF that can give rise to adipocytes,
may produce these proteins. Lastly, some early ADSC dif-
ferentiation into adipocytes may be occurring resulting in
an increase in the levels of these proteins. Differentiation
is unlikely as a source of these proteins because the widely
accepted method of in vitro ADSC differentiation into adi-
pocytes requires the use of differentiation media and takes
at least 2 weeks to complete [21]. Therefore, it is unlikely
that considerable differentiation of the ADSCs in the SVF
preparation occurred in the short-time frame of 3 days
in vitro prior to iTRAQ analysis. In addition, the presence
of mature adipocytes has been shown in vitro to inhibit
the differentiation of adherent adipose-derived cells into
adipocytes [35].
Of the proteins significantly down-regulated in the
proteome of the SVF cells co-cultured with the adipocytes
when compared to the isolated culture of the SVF, the
identification of fatty acid-binding protein, adipocyte
(FABP4) was of interest. It has been reported that
increased expression of the gene encoding this fatty acid-
binding protein promotes the differentiation of MSCs into
adipocytes [36]. Indeed, enhanced expression of the gene
encoding FABP4 has been reported from human ADSCs
grown on different scaffolds and subjected to adipogenicstimulants [37]. Therefore, it is possible that some of the
cells in the SVF cultured alone may have started to differ-
entiate into adipocytes due to the absence of mature adi-
pocytes. This may explain the increased levels of FABP4
measured in this sample. Any differentiation that had
initiated in the SVF or co-culture experiments would have
been at a preliminary stage when the cells were harvested.
An in-depth understanding of differentiation among
mixed cell populations in vitro would require considerably
increased culture time and the results would be different
from the in vivo situation.
Although a quantitative proteomic analysis of the SVF
co-cultured with adipocytes or cultured alone resulted in
the differential expression of 24 proteins, the functions of
these proteins do not indicate that a stress response is
being induced in the SVF under either condition. Instead,
it appears that the SVF cells are functioning normally at
the intra-cellular proteome level in vitro in the presence
or absence of adipocytes. A cellular therapeutic of either
the SVF supplemented with adipocytes or the SVF alone is
likely to be held for only minutes to hours before re-
introduction into the patient. Therefore, from this iTRAQ
data it appears that the absence or presence of adipocytes
is unlikely to have any significant effects on the intra-
cellular proteome of the SVF during this holding period.
However, the Bio-Plex data indicates that the cellular sig-
naling capacity of the SVF at the cytokine level is being
affected by the presence or absence of adipocytes.
Therapeutic importance
There have been numerous in vivo and in vitro studies
demonstrating the paracrine activities of ADSCs. The
use of freshly isolated populations from adipose tissue
such as the SVF, alone or in combination with adipo-
cytes, is becoming increasingly common as a cellular
therapy. This is not only due to the high frequency of
MSCs in adipose tissue, but also because the procedure
can be performed in-clinic under a medical exemption,
as the procedure is autologous, the tissue is minimally
manipulated and it is performed as an out-patient pro-
cedure under the responsibility of a registered medical
practitioner. Consequently the secretion profiles pro-
duced by these isolated and mixed cell populations are
of interest in order to delineate functional differences
and guide potential therapeutic use. Although this
in vitro study may not reflect the secretory activities of
these cell types in in vivo models of disease or real clin-
ical cases, it provides some insight into the secretion
capabilities of different adipose-derived cellular fractions.
These data also support the clinical results obtained via
the use of freshly isolated adipose-derived mixed cell
populations [3]. Furthermore, these adipose-derived
secretions may also be of importance for future off-the-
shelf secretion based therapeutics.
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of a variety of conditions has been trialed in both ani-
mals with induced diseases and humans with clinical
conditions. Given the pleiotropic nature and multi-
factorial roles of most cytokines, the introduction of a
single cytokine in an unregulated fashion is likely to
produce unwanted effects. Indeed, in a number of
studies, adverse reactions were observed [[38-40] and
references therein]. In some cases, the side effects
observed following administration of a single cytokine
were considered a direct consequence of inappropriate
immune system activation. Furthermore, the adminis-
tration of multiple bioactive factors has provided an
improved beneficial outcome over factors administered
individually [41-45].
Cellular therapy may offer advantages over administra-
tion of cytokines, as it appears the introduced cells are
able to respond to the local environment and as a result,
secrete an appropriate mixture of bioactive factors. The
relative ease of harvest of adipose tissue, compared to
bone marrow, makes it an ideal source of cells for au-
tologous cell therapy. Collagenase digestion of freshly
isolated adipose tissue typically produces millions of vi-
able cells per gram of fat, thus enabling day surgery in-
clinic procedures using autologous, uncultured mixed
cell populations. The use of adipose mixed cell popula-
tions such as the SVF with adipocytes may be an option
for the treatment of conditions where reduction of in-
flammation is a key aspect of the treatment. The thera-
peutic effect is likely to proceed in two phases after
in vivo implantation. Firstly, the freshly isolated, com-
bined population of SVF and adipocytes has the capacity
to secrete high levels of cytokines of therapeutic and
immuno-modulatory importance, such as IL-1Ra (Fig-
ure 3). Following in vivo introduction of the SVF with
adipocytes, it is possible that high levels of cytokines of
therapeutic importance may be produced. The high
levels of ADSCs in adipose SVF constitute the second
phase, where these cells are likely to embed in the host
tissue and continue to control the microenvironment
through their secretions including production of the
anti-inflammatory cytokines, IL-10 and IL-13 (Figure 3).
Indeed, ADSCs when introduced systemically can home
to the site of injury or inflammation, embed and stimu-
late regeneration of the tissue, through secretion of bio-
active factors that control the microenvironment [46,47].
However, embedding of non-stem cells cannot be dis-
counted when mixed cell populations are introduced. To
date, there has been no agreement in the literature
regarding a defined number of cells or minimal concen-
tration of cells or cytokines required to achieve a thera-
peutic outcome. Therefore further in vivo work needs to
be conducted in various disease models to define at least
the lower limits for efficacy.Conclusions
In this study we have demonstrated that a short-term
in vitro co-culture of SVF with adipocytes or isolated
culture of SVF does not have any negative effects on the
intra-cellular proteome of the SVF that would affect
their suitability as therapeutics. However, we illustrated
that the in vitro culture of various combinations of
human adipose-derived cell populations results in sig-
nificantly different cytokine secretion profiles. In par-
ticular, a combined culture of SVF and adipocytes results
in a distinct secretion profile when compared to the ‘in
silico’ dataset, produced by combining the secretion pro-
files of the isolated SVF with that of isolated adipocytes.
This illustrates that co-culture of the SVF with adipo-
cytes results in the cells acting in a synergistic manner
and modulating the production of cytokines by one or
more cell types. The use of a mixed cell population such
as the SVF with adipocytes may be considered for the
treatment of conditions which have inflammatory com-
ponents. The therapeutic effect is likely to proceed in
two phases after in vivo implantation. Firstly, the freshly
isolated, combined population of SVF and adipocytes
has the capacity to secrete high levels of cytokines of
therapeutic and immuno-modulatory importance, such
as IL-1Ra. Achieving a reduction in inflammation in
injured or inflamed tissues is required to firstly halt tis-
sue destruction and then subsequently enable tissue re-
pair to occur [48]. The high levels of ADSCs in adipose
SVF constitute the second phase, where these cells are
likely to embed in the host tissue, continue to control
the microenvironment through their paracrine activities
and stimulate the surrounding cells to repair and regen-
erate the damaged tissue [46,47,49].
Additional file
Additional file 1: Figure S1. Differentiation of adherent human
adipose-derived cells into adipogenic and osteogenic lineages.
Adherent cells were obtained from human lipoaspirate samples and
treated with standard differentiation media or control media. Adipogenic
differentiated (A) and control (B) cells were stained with Oil Red O to
visualize lipid accumulation. Osteogenic differentiated (C) and control (D)
cells were stained with Alizarin Red to visualize calcium deposition.
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